We are focused on expanding patient access to biologic drugs by delivering less expensive, equally effective biosimilars.
Valorum finds high quality assets to develop and commercialize, with a focus on markets that are currently underserved. Our pipeline is focused on high-value biosimilar drugs for ophthalmology and oncology indications.
Leadership with experience at top companies across pharma and drug distribution
Valorum is a disruptor, empowering companies to compete effectively in a space traditionally dominated by large incumbents.
We provide best-in-class execution for the regulatory approval, launch, and commercialization of biosimilars in the US. Our team brings unparalleled experience and established networks across the US pharmaceutical market and is focused on optimizing commercialization in order to improve access, reach, and cost savings for the healthcare system.